Accelerating Global Life Science & Pharmaceutical Innovation

Your Strategic Preclinical Research Partner

Outsourcing research and development (R&D) requires more than a transactional vendor—it demands a collaborative, technology-driven partnership backed by proven compliance and regulatory rigor.

MYCO2, a subsidiary of Singapore-listed LMS Compliance Ltd, partners with Dr. Can Bioscience (Hangzhou Deruikang) to provide full-service Contract Research Organisation (CRO) capabilities. We support pharmaceutical firms, biotechnology innovators, medical device developers, and academic research institutions worldwide.

By combining LMS Compliance Ltd’s regional testing framework with Dr. Can Bioscience’s specialized animal experiment center and technical laboratory infrastructure, MYCO2 bridges the gap between early scientific discovery and commercial viability.

Core Technology Platforms & Technical Services

Our non-standard biopharmaceutical research service platform delivers high-traceability, publication-ready data structured across eight dedicated technical service modules:

Animal Husbandry & Housing

Standardized SPF-grade housing, specialized diet/environmental management, and long-term cohort maintenance for experimental animals.

Assistive Operations & Surgical Models

Precision surgical modeling (e.g., spinal cord injury [SCI] models, cardiovascular ligation, tumor transplantation, and targeted organ interventions).

Disease Animal Models

Standard routine, induced, and genetically engineered animal models across oncology, neurology, metabolic, and inflammatory disease categories.

Biochemical Testing

High-precision enzymatic assays, metabolic marker profiling, tissue homogenate assays, and functional biomarker quantification.

Hematology & Urinalysis

Complete automated animal blood routine (CBC) panels, coagulation profiling, differential counts, and comprehensive urine chemistry testing.

Pathology & Histology Items

Tissue fixation, paraffin/frozen sectioning, H&E staining, IHC (Immunohistochemistry), IF (Immunofluorescence), and qualitative/quantitative histopathological evaluation.

Molecular Biology Projects

Target identification, gene expression profiling (qPCR/RT-PCR), Western Blot, ELISA, molecular cloning, and cell signal transduction assays.

Metabolomics & Data Analysis

Untargeted and targeted metabolomics profiling via LC-MS/GC-MS, coupled with advanced bioinformatic data processing, pathway analysis, and statistical visualization.

Comprehensive Preclinical Evaluation Capabilities

1. Pharmacokinetic & Pharmacodynamic (PK/PD) Assessments

   Understanding drug absorption, distribution, metabolism, and excretion (ADME) is vital for dose optimization. We conduct rigorous PK/PD evaluations in living systems to determine therapeutic windows and metabolic behavior.

2. Toxicology & Safety Testing

   Validate candidate safety prior to clinical trials. Our safety and toxicology assessments evaluate acute, sub-chronic, and organ-specific toxicity to align with international regulatory frameworks.

3. Advanced Diagnostic & Frontier Technologies

   For sophisticated bio-technological research, our extended network utilizes cutting-edge analytical tools, including:

   In Vivo Brain-Computer Interfaces (BCIs) for advanced neurological and neuromuscular studies.

   3D Electron Microscopy & Micro-CT for high-resolution anatomical and structural visualization.

   Multi-Omics Integration combining molecular data with docking simulations for precise biomarker discovery.

Our 5-Step Project Collaboration Model

We ensure complete scientific integrity, transparent communication, and periodic progress updates throughout every phase of your project:

Why Choose MYCO2, LMS Compliance Ltd & Dr. Can Bioscience?